Opioid Market Size, Share, Trends, Growth Outlook

Opioid Market is estimated to increase at a growth rate of 3.5% CAGR over the forecast period from 2024 to 2030.

The global Opioid Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (IR/Short Acting Opioids, ER/Long-Acting Opioids), By Application (Pain relief, Anesthesia, Cough suppression, Diarrhea suppression, De-addiction), By Route of Administration (Oral, Injectable, Others), Opioids Distribution Channel, Hospital pharmacy, Retail Pharmacy, Others).

An introduction to Opioid Market in 2024

Addressing pain management and anesthesia needs across various medical specialties, the Opioid Market offers a wide range of opioid medications including morphine, oxycodone, hydrocodone, and fentanyl, prescribed for acute and chronic pain relief, anesthesia induction, and palliative care. Opioids exert analgesic effects by binding to opioid receptors in the central nervous system, modulating pain perception, and altering neuronal signaling pathways. The market's growth is driven by the prevalence of pain-related conditions, surgical procedures, and cancer treatment, alongside factors such as opioid prescribing trends, regulatory policies, and public health initiatives aimed at mitigating opioid misuse, addiction, and overdose risks.

Opioid market Trend: Shift towards Non-Opioid Pain Management Alternatives

A significant trend in the Opioid market is the increasing focus on non-opioid pain management alternatives. With growing concerns over opioid addiction, misuse, and overdose, healthcare providers and policymakers are advocating for the use of non-opioid analgesics, adjuvant therapies, and interventional procedures to manage pain effectively. This trend reflects a broader shift towards multimodal pain management approaches, incorporating non-pharmacological interventions and alternative medications, thereby reducing reliance on opioids and mitigating associated risks.

Opioid market Driver: Rising Chronic Pain Prevalence and Aging Population

The primary driver in the Opioid market is the rising prevalence of chronic pain conditions, coupled with an aging population. Chronic pain affects millions of individuals worldwide, leading to significant morbidity, disability, and healthcare costs. As the global population ages, the incidence of chronic pain conditions, such as osteoarthritis, neuropathic pain, and cancer-related pain, is expected to increase, driving demand for opioid medications for pain relief. This demographic shift underscores the importance of effective pain management strategies and pharmaceutical interventions, propelling market growth in the opioid segment.

Opioid market Opportunity: Development of Abuse-Deterrent Formulations and Novel Pain Therapies

One potential opportunity in the Opioid market is the development of abuse-deterrent formulations and novel pain therapies. With heightened concerns regarding opioid abuse, manufacturers are investing in the research and development of abuse-deterrent opioid formulations that deter tampering, misuse, and diversion. Additionally, there's a need for innovative pain therapies that offer analgesic efficacy with reduced risk of addiction and adverse effects. Opportunities exist for pharmaceutical companies to innovate and introduce novel opioid formulations, such as extended-release formulations, combination therapies, and targeted delivery systems, addressing unmet medical needs while addressing public health concerns related to opioid misuse and abuse. By developing safer and more effective opioid medications, companies can navigate regulatory challenges, differentiate their products, and contribute to addressing the opioid epidemic.

Opioid Market Market Segmentation

By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Opioid Market Companies

AbbVie Inc
AcelRx Pharmaceuticals Inc
Alcaliber SA
Amneal Pharmaceuticals Inc
Endo Pharmaceuticals Inc
Hikma Pharmaceuticals PLC
Johnson and Johnson
Mallinckrodt Pharmaceuticals LLC
Pfizer Inc
Purdue Pharmaceuticals L.P.
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Inc
Vertice Pharma LLC
Zyla Life Sciences

Reasons to Buy the Opioid Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Opioid Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Opioid Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Opioid Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Opioid Market Size Outlook, $ Million, 2021 to 2030
3.2 Opioid Market Outlook by Type, $ Million, 2021 to 2030
3.3 Opioid Market Outlook by Product, $ Million, 2021 to 2030
3.4 Opioid Market Outlook by Application, $ Million, 2021 to 2030
3.5 Opioid Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Opioid Industry
4.2 Key Market Trends in Opioid Industry
4.3 Potential Opportunities in Opioid Industry
4.4 Key Challenges in Opioid Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Opioid Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Opioid Market Outlook by Segments
7.1 Opioid Market Outlook by Segments, $ Million, 2021- 2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

8 North America Opioid Market Analysis and Outlook To 2030
8.1 Introduction to North America Opioid Markets in 2024
8.2 North America Opioid Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Opioid Market size Outlook by Segments, 2021-2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

9 Europe Opioid Market Analysis and Outlook To 2030
9.1 Introduction to Europe Opioid Markets in 2024
9.2 Europe Opioid Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Opioid Market Size Outlook by Segments, 2021-2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

10 Asia Pacific Opioid Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Opioid Markets in 2024
10.2 Asia Pacific Opioid Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Opioid Market size Outlook by Segments, 2021-2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

11 South America Opioid Market Analysis and Outlook To 2030
11.1 Introduction to South America Opioid Markets in 2024
11.2 South America Opioid Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Opioid Market size Outlook by Segments, 2021-2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

12 Middle East and Africa Opioid Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Opioid Markets in 2024
12.2 Middle East and Africa Opioid Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Opioid Market size Outlook by Segments, 2021-2030
By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie Inc
AcelRx Pharmaceuticals Inc
Alcaliber SA
Amneal Pharmaceuticals Inc
Endo Pharmaceuticals Inc
Hikma Pharmaceuticals PLC
Johnson and Johnson
Mallinckrodt Pharmaceuticals LLC
Pfizer Inc
Purdue Pharmaceuticals L.P.
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Inc
Vertice Pharma LLC
Zyla Life Sciences
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
IR/Short Acting Opioids
ER/Long-Acting Opioids
By IR/Short Acting Opioids
Immediate- Release/Short-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Immediate- Release/Short-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By ER/Long-Acting Opioids
Extended-Release/Long-Acting Opioid by Product
-Codeine
-Oxycodone
-Hydrocodone
-Fentanyl
-Morphine
-Hydroxymorphone
-Oxymorphone
-Propoxyphene
-Others
Extended-Release/Long-Acting Opioid by Application
-Pain relief
-Anesthesia
-Cough suppression
-Diarrhea suppression
-De-addiction
By Application
Pain relief
Anesthesia
Cough suppression
Diarrhea suppression
De-addiction
By Route of administration
Oral
Injectable
Others
Opioids Distribution Channel
Hospital pharmacy
Retail Pharmacy
Others